✦ LIBER ✦

Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy

✍ Scribed by Catharina Wenzel; Gottfried J. Locker; Manuela Schmidinger; Robert Mader; Gero Kramer; Michael Marberger; Michael Rauchenwald; Cristoph C. Zielinski; Guenther G. Steger

Book ID: 114463481
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 52 KB
Volume: 39
Category: Article
ISSN: 0272-6386
DOI: 10.1053/ajkd.2002.29879

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine in the treatment of metasta

Capecitabine in the treatment of metastatic renal cell carcinoma

✍ Oevermann, K; Buer, J; Hoffmann, R; Franzke, A; Schrader, A; Patzelt, T; Kirchne 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB

903 Capecitabine-monotherapy and in comb

903 Capecitabine-monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinoma

✍ C. Wenzel; R. Bartsch; U. Pluschinig; D. Hussian; C.C. Zielinski; G.G. Steger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Immunotherapy in metastatic renal cell c

Immunotherapy in metastatic renal cell carcinoma

✍ Karl Rohrmann; Michael Staehler; Nikolas Haseke; Alexander Bachmann; Christian G 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 237 KB

Immunotherapy of metastatic renal cell c

Immunotherapy of metastatic renal cell carcinoma

✍ David F. McDermott 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

T-cell adoptive immunotherapy of metasta

T-cell adoptive immunotherapy of metastatic renal cell carcinoma

✍ Gregory E Plautz; Ronald M Bukowski; Andrew C Novick; Eric A Klein; Elroy D Kurs 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Prognostic factors of immunotherapy in m

Prognostic factors of immunotherapy in metastatic renal cell carcinoma

✍ Peeter Padrik 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 97 KB